a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance
Industry Biotechnology
A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with KYMR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then KYMR could also see price increases.
Ticker / NAME | Correlation To ORIC | 1D Price Change % | ||
---|---|---|---|---|
ORIC | 100% | -1.69% | ||
KYMR - ORIC | 41% Loosely correlated | +2.82% | ||
ACLX - ORIC | 40% Loosely correlated | -0.42% | ||
DAWN - ORIC | 40% Loosely correlated | +0.74% | ||
ATXS - ORIC | 40% Loosely correlated | -1.74% | ||
PRTA - ORIC | 39% Loosely correlated | +2.49% | ||
More |